Creative Planning
STRO icon

Creative Planning’s Sutro Biopharma STRO Stock Holding History

Creative Planning’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,064
Closed -$107K – 2453
2020
Q3 		$107K Sell
1,064
-1,063
-50% -$100K ﹤0.01% 1816
2020
Q2 		$165K Hold
2,127
– – ﹤0.01% 1576
2020
Q1 		$217K Hold
2,127
– – ﹤0.01% 1355
2019
Q4 		$234K Sell
2,127
-1,024
-32% -$106K ﹤0.01% 1554
2019
Q3 		$286K Hold
3,151
– – ﹤0.01% 1392
2019
Q2 		$359K Buy
+3,151
New +$347K ﹤0.01% 1264

Other funds holding STRO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Creative Planning's STRO Position: Q4 2020 in Review

Creative Planning sold out of Sutro Biopharma (STRO) in Q4 2020, closing a stake of 1,064 shares — an estimated $107K sold.

Creative Planning first reported a position in STRO in Q2 2019 and held it in 6 quarters. The position peaked at $359K in Q2 2019. 134 funds tracked by Wall St. Rank hold STRO as of Q4 2020.

  • Creative Planning reported no remaining Sutro Biopharma position as of Q4 2020 after selling out during the quarter.
  • Creative Planning sold 1,064 Sutro Biopharma shares in Q4 2020, an estimated $107K.
  • Creative Planning first reported a position in Sutro Biopharma in Q2 2019 and held it in 6 quarters.
  • Creative Planning's Sutro Biopharma position peaked at $359K in Q2 2019.
  • 134 funds tracked by Wall St. Rank held Sutro Biopharma as of Q4 2020.

Based on Creative Planning's 13F filing for Q4 2020, filed 29 Jan 2021.